Jiangsu Sihuan Bioengineering Co., Ltd (SHE:000518)
China · Delayed Price · Currency is CNY 2.990
+0.010 (0.34%)
Apr 21, 2026, 3:04 PM CST
SHE:000518 Revenue
In the year 2025, Jiangsu Sihuan Bioengineering had annual revenue of 344.38M CNY with 69.22% growth. Jiangsu Sihuan Bioengineering had revenue of 50.01M in the quarter ending December 31, 2025, with 5.23% growth.
Revenue
344.38M
Revenue Growth
+69.22%
P/S Ratio
8.94
Revenue / Employee
1.24M
Employees
277
Market Cap
3.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 344.38M | 140.87M | 69.22% |
| Dec 31, 2024 | 203.52M | -31.90M | -13.55% |
| Dec 31, 2023 | 235.42M | -34.73M | -12.86% |
| Jan 1, 2023 | 270.15M | -80.81M | -23.03% |
| Jan 1, 2022 | 350.96M | -154.44M | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Kawin Technology Share-Holding | 1.15B |
| Shandong Sito Bio-technology | 954.76M |
| Guangdong VTR Bio-Tech | 830.87M |
| Cabio Biotech (Wuhan) | 574.88M |
| Suzhou Fushilai Pharmaceutical | 439.57M |
| Shanghai Model Organisms Center | 421.26M |
| Yantai Zhenghai Biotechnology | 347.75M |
| Shenzhen Bioeasy Biotechnology | 251.83M |